1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research & Forecasting
2.1. Research Methodology
2.1.1. Research Process
2.1.2. Research Framework
2.1.3. Research Reliability & Validity
2.1.4. Research Assumptions
2.2. Forecasting Methodology
2.3. Research Outcome
2.3.1. 360iResearch Competitive Strategic Window
2.3.1.1. Leverage Zone
2.3.1.2. Vantage Zone
2.3.1.3. Speculative Zone
2.3.1.4. Bottleneck Zone
2.3.2. 360iResearch FPNV Positioning Matrix
2.3.2.1. 360iResearch Quadrants
2.3.2.1.1. Forefront
2.3.2.1.2. Pathfinders
2.3.2.1.3. Niche
2.3.2.1.4. Vital
2.3.2.2. Business Strategy
2.3.2.2.1. Business Growth
2.3.2.2.2. Industry Coverage
2.3.2.2.3. Financial Viability
2.3.2.2.4. Channel Support
2.3.2.3. Product Satisfaction
2.3.2.3.1. Value for Money
2.3.2.3.2. Ease of Use
2.3.2.3.3. Product Features
2.3.2.3.4. Customer Support
3. Executive Summary
3.1. Outlook in the Digital Pathology Market
3.1.1. Digital pathology is continuously focusing on improving the quality and efficiency of pathology services.
3.1.2. One of the key trends observed in the digital pathology market is the transition to cloud-based delivery of the solutions which has decreased the IT staff burden and has proven to reduce the need for costly IT infrastructure and installation time
3.1.3. The market is highly competitive characterized by strategic partnerships as an essential tool for market growth
3.1.4. Deep Lens collects another Series A round funding of USD 13.7 million for digital pathology
3.1.5. U.K. to invest USD 65 million to set up five new AI digital pathology and imaging centers
3.2. Opportunities in the Digital Pathology Market
3.3. Geographical Analysis in the Digital Pathology Market
4. Premium Insight
4.1. Market Connectivity
4.2. Market Dynamics
4.2.1. Drivers
4.2.1.1. Quality improvement in service delivery
4.2.1.2. Increasing prevalence of chronic disease
4.2.1.3. Technological advancement in healthcare
4.2.2. Restraints
4.2.2.1. High cost system and lack of standards
4.2.3. Opportunities
4.2.3.1. Streamline drug development processes in discovery, pre-clinical and clinical trials
4.2.3.2. Evolving technologies improve the pathologist’s workstation experience
4.2.3.3. Increasing use in education, research, and training
4.2.4. Challenges
4.2.4.1. Legal barriers and cultural resistance
4.2.4.2. Data management and storage challenges
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Customers
4.3.4. Bargaining Power of Suppliers
4.3.5. Industry Rivalry
4.4. Industry Trends
5. Global Digital Pathology Market, by Deployment
5.1. Overview
5.2. Market Sizing & Forecasting
5.3. On-Cloud
5.4. On-Premises
6. Global Digital Pathology Market, by End User
6.1. Overview
6.2. Market Sizing & Forecasting
6.3. Academic & Research Institutes
6.4. Infectious Diseases
6.5. Laboratories
6.6. Pharmaceutical & Biotechnology Companies
7. Americas Digital Pathology Market Estimates & Trend Analysis
7.1. Overview
7.2. Market Sizing & Forecasting
7.3. Canada
7.4. Mexico
7.5. United States
8. Asia-Pacific Digital Pathology Market Estimates & Trend Analysis
8.1. Overview
8.2. Market Sizing & Forecasting
8.3. China
8.4. India
8.5. Japan
9. Europe, Middle East & Africa Digital Pathology Market Estimates & Trend Analysis
9.1. Overview
9.2. Market Sizing & Forecasting
9.3. France
9.4. Germany
9.5. United Kingdom
10. Competitive Landscape
10.1. 360iResearch FPNV Positioning Matrix for Global Digital Pathology Market
10.2. Market Vendor Ranking Analysis for Global Digital Pathology Market
10.3. Competitive News Feed Analysis for Global Digital Pathology Market
11. Company Usability Profiles
11.1. Hamamatsu Photonics K.K.
11.1.1. Overview
11.1.2. Strategy
11.1.3. SWOT
11.1.4. Scorecard
11.2. Huron Digital Pathology
11.2.1. Overview
11.2.2. Strategy
11.2.3. SWOT
11.2.4. Scorecard
11.3. Leica Biosystems Nussloch Gmbh
11.3.1. Overview
11.3.2. Strategy
11.3.3. SWOT
11.3.4. Scorecard
11.4. OptraSCAN, Inc.
11.4.1. Overview
11.4.2. Strategy
11.4.3. SWOT
11.4.4. Scorecard
11.5. Ventana Medical Systems, Inc.
11.5.1. Overview
11.5.2. Strategy
11.5.3. SWOT
11.5.4. Scorecard
11.6. 3DHISTECH Ltd
11.6.1. Overview
11.6.2. Strategy
11.6.3. SWOT
11.6.4. Scorecard
11.7. Corista LLC
11.7.1. Overview
11.7.2. Strategy
11.7.3. SWOT
11.7.4. Scorecard
11.8. DeepBio, Inc.
11.8.1. Overview
11.8.2. Strategy
11.8.3. SWOT
11.8.4. Scorecard
11.9. Definiens, Inc.
11.9.1. Overview
11.9.2. Strategy
11.9.3. SWOT
11.9.4. Scorecard
11.10. Indica Labs
11.10.1. Overview
11.10.2. Strategy
11.10.3. SWOT
11.10.4. Scorecard
11.11. Inspirata, Inc.
11.11.1. Overview
11.11.2. Strategy
11.11.3. SWOT
11.11.4. Scorecard
11.12. Philips Healthcare
11.12.1. Overview
11.12.2. Strategy
11.12.3. SWOT
11.12.4. Scorecard
11.13. Proscia, Inc.
11.13.1. Overview
11.13.2. Strategy
11.13.3. SWOT
11.13.4. Scorecard
11.14. Sectra AB
11.14.1. Overview
11.14.2. Strategy
11.14.3. SWOT
11.14.4. Scorecard
11.15. Visiopharm
11.15.1. Overview
11.15.2. Strategy
11.15.3. SWOT
11.15.4. Scorecard
12. Appendix
12.1. Discussion Guide
12.2. Top Reports
12.2.1. Global Vaccine Contract Manufacturing Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.2. Global Stem Cells Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.3. Global Self-Checkout Systems Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.2.4. Global Passenger Security Systems Market - Premium Insight, Competitive News Feed Analysis, Company Usability Profiles, Market Sizing & Forecasts to 2025
12.3. Author Details
